Speak directly to the analyst to clarify any post sales queries you may have.
Life sciences refer to the unit of science that studies living organisms, including biology, botany, zoology, microbiology, physiology, and biochemistry. Various instruments, consumables, reagents, and other services are used to study life science. The prevalence of chronic diseases worldwide is raising the need for improved tools for the early diagnosis of diseases. The favorable investment landscape to accelerate R&D in the biotechnological sector for its implications in health and medicine facilitates using life science tools. However, the high cost of implementation and maintenance and the quality control issues associated with using life science tools may impede their adoption by the end-use industries. Moreover, the rising applications of genomics and proteomics for precision medicine and breakthrough advancements in life science tools are expected to encourage their deployment across the end-use industries.
Regional Insights
The life science tools market is evolving in the Americas owing to the highly valued medical and pharmaceutical sector, rapid adoption of genomics, proteomics, oncology, and diagnostic screening, and major players continuously developing advanced tools for life science research. A well-regulated environment for approvals and usage of genomic and tissue diagnostic tests is encouraging the life science tools market growth in the Americas. Increasing research and development (R&D) expenditure to advance medical research and the growing adoption of innovative and advanced tools among biopharmaceutical companies are facilitating the use of life science tools in the APAC region. Rising investments in research and development of healthcare and pharmaceutical products, growing consumer expenditure on advanced healthcare products to treat chronic diseases, and supportive government initiatives for life science and pharmaceutical sector development are expanding the utilization of life science tools in the EMEA region. The ongoing collaborations, acquisitions, and embracing of digital technologies can increase production and are expected to contribute to the growth of the life science tools market worldwide.FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Life Science Tools Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Life Science Tools Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.Key Company Profiles
The report delves into recent significant developments in the Life Science Tools Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., 3M Company, Abbott Laboratories, Abcam PLC, Agilent Technologies, Inc., Avantor, Inc., B. Braun SE, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corporation, bioMérieux SA, Bruker Corporation, Cardinal Health, Inc., Carl Zeiss AG, Charles River Laboratories International, Inc., Danaher Corporation, Diagnóstica Longwood S.L., Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche Ltd., Fulgent Genetics, Inc., GE Healthcare Technologies Inc., Genscript Biotech Corporation, Hitachi, Ltd., HORIBA, Ltd., ICON PLC, Illumina, Inc., IQVIA Holdings Inc., Laboratory Corporation of America Holdings, Lonza Group Ltd., Luminex Corporation, Merck KGaA, Mettler-Toledo International Inc., New England Biolabs, Inc., Oxford Instruments PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Quest Diagnostics Incorporated, Repligen Corporation, Sartorius AG, SGS SA, Shimadzu Corporation, Takara Bio Inc., Tecan Trading AG, Thermo Fisher Scientific Inc., Waters Corporation, and WuXi AppTec Co., Ltd.Market Segmentation & Coverage
This research report categorizes the Life Science Tools Market to forecast the revenues and analyze trends in each of the following sub-markets:- Technology
- Cell Biology Technology
- Genomic Technology
- Proteomics Technology
- Product
- Cell Culture Systems & 3D Cell Culture
- Media
- Reagents
- Sera
- Cloning & Genome Engineering
- Flow Cytometry
- Liquid Chromatography
- Mass Spectrometry
- Microscopy & Electron Microscopy
- Next Generation Sequencing
- Nuclear Magnetic Resonance
- Nucleic Acid Microarray
- Nucleic Acid Preparation
- PCR & qPCR
- Sanger Sequencing
- Transfection Devices & Gene Delivery Technologies
- Cell Culture Systems & 3D Cell Culture
- Offerings
- Consumables
- Instrument
- Services
- Lab Ownership
- Private
- Public
- Lab Size
- Large
- Medium
- Small
- End-User
- Academic Research Institutes
- Biotechnology Companies
- Contract Research Organization/ Contract Manufacturing Organization
- Diagnostic Laboratories
- Hospitals
- Region
- Americas
- Argentina
- Brazil
- Canada
- Mexico
- United States
- California
- Florida
- Illinois
- New York
- Ohio
- Pennsylvania
- Texas
- Asia-Pacific
- Australia
- China
- India
- Indonesia
- Japan
- Malaysia
- Philippines
- Singapore
- South Korea
- Taiwan
- Thailand
- Vietnam
- Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom
- Americas
The report offers valuable insights on the following aspects
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as
- What is the market size and forecast of the Life Science Tools Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Life Science Tools Market?
- What are the technology trends and regulatory frameworks in the Life Science Tools Market?
- What is the market share of the leading vendors in the Life Science Tools Market?
- Which modes and strategic moves are suitable for entering the Life Science Tools Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.
This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.
Table of Contents
Companies Mentioned
- 10x Genomics, Inc.
- 3M Company
- Abbott Laboratories
- Abcam PLC
- Agilent Technologies, Inc.
- Avantor, Inc.
- B. Braun SE
- Becton, Dickinson, and Company
- Bio-Rad Laboratories, Inc.
- Bio-Techne Corporation
- bioMérieux SA
- Bruker Corporation
- Cardinal Health, Inc.
- Carl Zeiss AG
- Charles River Laboratories International, Inc.
- Danaher Corporation
- Diagnóstica Longwood S.L.
- Eppendorf SE
- Eurofins Scientific SE
- F. Hoffmann-La Roche Ltd.
- Fulgent Genetics, Inc.
- GE Healthcare Technologies Inc.
- Genscript Biotech Corporation
- Hitachi, Ltd.
- HORIBA, Ltd.
- ICON PLC
- Illumina, Inc.
- IQVIA Holdings Inc.
- Laboratory Corporation of America Holdings
- Lonza Group Ltd.
- Luminex Corporation
- Merck KGaA
- Mettler-Toledo International Inc.
- New England Biolabs, Inc.
- Oxford Instruments PLC
- PerkinElmer, Inc.
- Promega Corporation
- QIAGEN N.V.
- Quest Diagnostics Incorporated
- Repligen Corporation
- Sartorius AG
- SGS SA
- Shimadzu Corporation
- Takara Bio Inc.
- Tecan Trading AG
- Thermo Fisher Scientific Inc.
- Waters Corporation
- WuXi AppTec Co., Ltd
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 187 |
Published | March 2024 |
Forecast Period | 2023 - 2030 |
Estimated Market Value ( USD | $ 203.93 Billion |
Forecasted Market Value ( USD | $ 429.19 Billion |
Compound Annual Growth Rate | 11.1% |
Regions Covered | Global |
No. of Companies Mentioned | 48 |